In a groundbreaking announcement, gene therapy company uniQure revealed an experimental treatment that has slowed the progression of Huntington's disease. Although still in early testing, this could signal new hope for patients battling this devastating condition.
A new blood test developed by experts at Washington University and Lund University could change the way Alzheimer’s is diagnosed and treated, identifying disease progression and guiding personalized care.
